![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/01/GSK620-is-a-Potent-and-Orally-Active-pan-BET-BD2-Inhibitor-2020-01-08.jpg)
The therapeutic potential of extra terminal domain inhibitor (iBET) has increasing studies both in oncology and immunoinflammatory. Moreover, iBETs are…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/09/RBN012759-is-a-Selective-and-Orally-Active-Inhibitor-of-PARP14-2020-10-14.jpg)
Poly (ADP ribose) polymerase (PARP) is a family of proteins involved in many cellular processes, such as DNA repair, genomic…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/09/PF06650833-is-an-Orally-Active-IRAK4-Inhibitor-2020-09-15.jpg)
Interleukin-1 receptor-associated kinase 4 (IRAK4) is a key node in innate inflammatory signaling. It is also directly downstream of the…
Tumor angiogenesis plays an essential role in carcinogenesis, cancer progression, and metastasis. The inflammation is a key feature of the…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/04/CMS-121-is-an-Orally-Active-Acetyl-CoA-Carboxylase-1-ACC1-Inhibitor-2020-04-23.jpg)
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. In this study,…